Hively Bradinsider trades

In SEC Form 4 filings, Hively Brad is listed as Director of Starling Oncology, Inc. (STLN). In the last 90 days, Hively Brad sold $1.95M of Starling Oncology, Inc. (STLN) on the open market and bought none. The sale was reported under a 10b5-1 trading plan.

Companies and roles

Company	Role	Transactions	Last filed
STLNStarling Oncology, Inc.	Director	1	Aug 24

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-08-24

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
STLNStarling Oncology, Inc.	Aug 21	Aug 24	S	298,853	$6.51	Sale −$1,946,310	411,976	Yes	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.